BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+28.43%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$15.2B
AUM Growth
+$15.2B
Cap. Flow
-$49.8M
Cap. Flow %
-0.33%
Top 10 Hldgs %
84.66%
Holding
127
New
12
Increased
13
Reduced
22
Closed
28
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
EXEL icon
101
Exelixis
EXEL
$9.95B
-513,410
Closed -$11M
CBIO
102
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
-2,912
Closed -$4.7M
MDWD icon
103
MediWound
MDWD
$180M
-32,286
Closed -$1.56M
MGNX icon
104
MacroGenics
MGNX
$121M
-217,695
Closed -$4.5M
NTRA icon
105
Natera
NTRA
$23B
-228,676
Closed -$4.3M
RIGL icon
106
Rigel Pharmaceuticals
RIGL
$710M
-104,161
Closed -$2.95M
RNAC icon
107
Cartesian Therapeutics
RNAC
$267M
-3,125
Closed -$1.24M
TNXP icon
108
Tonix Pharmaceuticals
TNXP
$243M
0
-$3.11M
VNDA icon
109
Vanda Pharmaceuticals
VNDA
$279M
-310,354
Closed -$5.91M
LUMO
110
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
-56,364
Closed -$2.42M
TRVN
111
DELISTED
Trevena, Inc.
TRVN
-1,520
Closed -$1.37M
TTOO
112
DELISTED
T2 Biosystems, Inc
TTOO
-20
Closed -$774K
ACOR
113
DELISTED
Acorda Therapeutics, Inc.
ACOR
-1,443
Closed -$4.97M
JNCE
114
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-100,000
Closed -$766K
AERI
115
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
-60,155
Closed -$4.06M
NBRV
116
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
-3,753
Closed -$3.27M
TTPH
117
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
-46,750
Closed -$3.34M
PGNX
118
DELISTED
Progenics Pharmaceuticals Inc
PGNX
-979,016
Closed -$7.87M
STML
119
DELISTED
Stemline Therapeutics, Inc.
STML
-44,524
Closed -$715K
BTX.WS
120
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
-20,084
Closed -$1K
BDSI
121
DELISTED
BioDelivery Sciences International, Inc.
BDSI
-210,021
Closed -$620K